Skip to main content
Erschienen in: Journal of Clinical Immunology 7/2015

01.10.2015 | Original Research

Primary Immunodeficiency Diseases in Saudi Arabia: a Tertiary Care Hospital Experience over a Period of Three Years (2010–2013)

verfasst von: Bandar Al-Saud, Hamoud Al-Mousa, Sulaiman Al Gazlan, Abdulaziz Al-Ghonaium, Rand Arnaout, Amal Al-Seraihy, Sahar Elshorbagi, Nazeema Elsayed, Jawad Afzal, Hasan Al-Dhekri, Saleh Al-Muhsen

Erschienen in: Journal of Clinical Immunology | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Primary immunodeficiencies (PID) are a group of heterogeneous diseases. Epidemiological studies from databases worldwide show geographical variation. In this study the objective is to determine the spectrum of PID in Saudi Arabia by analyzing the database in a referral tertiary hospital.

Methods

This is a prospective data collection by interviews and medical chart review for all PID patients followed at the King Faisal Specialist Hospital & Research Center (KFSH&RC) from May 2010 to April 2013.

Results

A total of 502 patients presented (53 % male and 47 % female). Combined immunodeficiencies were the most common (59.7 %), followed by predominantly antibody deficiencies (12.3 %), congenital defects of phagocyte (9.4 %), combined immunodeficiencies with associated or syndromic features (6.2 %), disease of immune dysregulation (6 %), complement deficiencies (5.8), and defects in innate immunity (0.6 %). The most common combined immunodeficiencies phenotype was T-B-SCID (17 %). The patients’ ages ranged from less than 1 year old to 78 years, and 394 patients (78.2 %) are in the paediatrics age group (<14 years). The overall mean age of symptoms onset was 17 months and the overall mean delay in diagnosis was 21.6 months. Recurrent infections were the most common occurring clinical presentation (66 %), followed by family history (26 %). Consanguinity was found in 75 % of the patients. A total of 308 (61 %) patients had undergone stem cell transplantation (SCT).

Conclusion

The study revealed that combined immunodeficiencies are not uncommon and are the most frequent occurring diagnosis in our patient population. This study is a prerequisite to establish a national registry of primary immunodeficiency in Saudi Arabia.
Literatur
1.
Zurück zum Zitat Edgar J, Buckland M, Guzman D, Conlon N, Knerr V, Bangs C, et al. The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years’ activity 2008–2012. Clin Exp Immunol. 2013;175:68–78.PubMedCentralCrossRef Edgar J, Buckland M, Guzman D, Conlon N, Knerr V, Bangs C, et al. The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years’ activity 2008–2012. Clin Exp Immunol. 2013;175:68–78.PubMedCentralCrossRef
2.
Zurück zum Zitat The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010; 135:264–72. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010; 135:264–72.
3.
Zurück zum Zitat Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. 2007;27:517–24.CrossRefPubMed Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. 2007;27:517–24.CrossRefPubMed
4.
Zurück zum Zitat Errante PR, Franco JL, Espinosa-Rosales FJ, Sorensen R, Condino-Neto A. Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives. Ann N Y Acad Sci. 2012;1250:62–72.CrossRefPubMed Errante PR, Franco JL, Espinosa-Rosales FJ, Sorensen R, Condino-Neto A. Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives. Ann N Y Acad Sci. 2012;1250:62–72.CrossRefPubMed
5.
Zurück zum Zitat Ishimura M, Takada H, Doi T, Imai K, Sasahara Y, Kanegane H, et al. Nationwide survey of patients with primary immunodeficiency diseases in Japan. J Clin Immunol. 2011;31:968–76.CrossRefPubMed Ishimura M, Takada H, Doi T, Imai K, Sasahara Y, Kanegane H, et al. Nationwide survey of patients with primary immunodeficiency diseases in Japan. J Clin Immunol. 2011;31:968–76.CrossRefPubMed
6.
Zurück zum Zitat Al Herz W. Primary immunodeficiency disorders in kuwait: first report from Kuwait national primary immunodeficiency registry (2004–2006). J Clin Immunol. 2008;28:186–93.CrossRefPubMed Al Herz W. Primary immunodeficiency disorders in kuwait: first report from Kuwait national primary immunodeficiency registry (2004–2006). J Clin Immunol. 2008;28:186–93.CrossRefPubMed
7.
Zurück zum Zitat Al-Tamemi S, Elnour I, Dennison D. Primary immunodeficiency diseases in Oman: five years’ experience at Sultan Qaboos University Hospital. WAO J. 2012;5:52–6. Al-Tamemi S, Elnour I, Dennison D. Primary immunodeficiency diseases in Oman: five years’ experience at Sultan Qaboos University Hospital. WAO J. 2012;5:52–6.
8.
Zurück zum Zitat Reda S, Afifi H, Amine M. Primary immunodeficiency diseases in Egyptian children: a single-center study. J Clin Immunol. 2009;29:343–51.CrossRefPubMed Reda S, Afifi H, Amine M. Primary immunodeficiency diseases in Egyptian children: a single-center study. J Clin Immunol. 2009;29:343–51.CrossRefPubMed
9.
Zurück zum Zitat Barbouche MR, Galal N, Ben-Mustapha I, Jeddane L, Mellouli F, et al. Primary immunodeficiencies in highly consanguineous North African populations. Ann N Y Acad Sci. 2011;1238:42–52.CrossRefPubMed Barbouche MR, Galal N, Ben-Mustapha I, Jeddane L, Mellouli F, et al. Primary immunodeficiencies in highly consanguineous North African populations. Ann N Y Acad Sci. 2011;1238:42–52.CrossRefPubMed
10.
Zurück zum Zitat Aghamohammadi A, Mohammadinejad P, Abolhassani H, Mirminachi B, Movahedi M, Gharagozlou M, et al. Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry. J Clin Immunol. 2014;34(4):478–90.CrossRefPubMed Aghamohammadi A, Mohammadinejad P, Abolhassani H, Mirminachi B, Movahedi M, Gharagozlou M, et al. Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry. J Clin Immunol. 2014;34(4):478–90.CrossRefPubMed
11.
Zurück zum Zitat Gathmann B, Goldacker S, Klima M, Belohradsky BHG, Notheis G, Ehl S. The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol. 2013;173(2):372–80.PubMedCentralCrossRefPubMed Gathmann B, Goldacker S, Klima M, Belohradsky BHG, Notheis G, Ehl S. The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol. 2013;173(2):372–80.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Naidoo R, Ungerer L, Cooper M, Pienaar S, Eley B. Primary immunodeficiencies: a 27-year review at a Tertiary Paediatric Hospital in Cape Town. South Afr J Clin Immunol. 2011;31:99–105.CrossRef Naidoo R, Ungerer L, Cooper M, Pienaar S, Eley B. Primary immunodeficiencies: a 27-year review at a Tertiary Paediatric Hospital in Cape Town. South Afr J Clin Immunol. 2011;31:99–105.CrossRef
13.
Zurück zum Zitat Gathmann B, Binder N, Ehl S, Kindle G, ESID Registry Working Party. The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol. 2012;167(3):479–91.PubMedCentralCrossRefPubMed Gathmann B, Binder N, Ehl S, Kindle G, ESID Registry Working Party. The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol. 2012;167(3):479–91.PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Javier F, Moore C, Sorensen R. Distribution of primary immunodeficiency diseases diagnosed in a pediatric tertiary hospital. Ann Allergy Asthma Immunol. 2000;84:25–30.CrossRefPubMed Javier F, Moore C, Sorensen R. Distribution of primary immunodeficiency diseases diagnosed in a pediatric tertiary hospital. Ann Allergy Asthma Immunol. 2000;84:25–30.CrossRefPubMed
15.
Zurück zum Zitat Al Attas R, Rahi A. Primary antibody deficiency in Arabs: first report from Eastern Saudi Arabia. J Clin Immunol. 1998;5(18):368–71.CrossRef Al Attas R, Rahi A. Primary antibody deficiency in Arabs: first report from Eastern Saudi Arabia. J Clin Immunol. 1998;5(18):368–71.CrossRef
16.
Zurück zum Zitat Suliaman F, Al- Ghonaium A, Harfi H. High incidence of severe combined immune deficiency in the Eastern Province of Saudi Arabia. Paediatr Asthma, Allergy Immunol. 2006;19(1):14–8.CrossRef Suliaman F, Al- Ghonaium A, Harfi H. High incidence of severe combined immune deficiency in the Eastern Province of Saudi Arabia. Paediatr Asthma, Allergy Immunol. 2006;19(1):14–8.CrossRef
17.
Zurück zum Zitat Al-Odaib AN, Abu-Amero KK, Ozand PT, Al-Hellani AM. A new era for preventive genetic programs in the Arabian Peninsula. Saudi Med J. 2003;24(11):1168–75.PubMed Al-Odaib AN, Abu-Amero KK, Ozand PT, Al-Hellani AM. A new era for preventive genetic programs in the Arabian Peninsula. Saudi Med J. 2003;24(11):1168–75.PubMed
18.
Zurück zum Zitat Alsmadi O, Al-Ghonaium A, Al-Muhsen S, Arnaout R, Al-Dhekri H, Al-Saud B, et al. Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia. BMC Med Genet. 2009;10:116.PubMedCentralCrossRefPubMed Alsmadi O, Al-Ghonaium A, Al-Muhsen S, Arnaout R, Al-Dhekri H, Al-Saud B, et al. Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia. BMC Med Genet. 2009;10:116.PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Alsum Z, Hawwari A, Alsmadi O, Al-Hissi S, Borrero E, Abu-Staiteh A, et al. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty five patients. J Clin Immunol. 2013;33(1):55–67.CrossRefPubMed Alsum Z, Hawwari A, Alsmadi O, Al-Hissi S, Borrero E, Abu-Staiteh A, et al. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty five patients. J Clin Immunol. 2013;33(1):55–67.CrossRefPubMed
20.
Zurück zum Zitat Al-Saud B, Al-Sum Z, Alassiri H, Al-Ghonaium A, Al-Muhsen S, Al-Dhekri H, et al. Clinical, immunological, and molecular characterization of hyper-IgM syndrome due to CD40 deficiency in eleven patients. J Clin Immunol. 2013;33(8):1325–35.CrossRefPubMed Al-Saud B, Al-Sum Z, Alassiri H, Al-Ghonaium A, Al-Muhsen S, Al-Dhekri H, et al. Clinical, immunological, and molecular characterization of hyper-IgM syndrome due to CD40 deficiency in eleven patients. J Clin Immunol. 2013;33(8):1325–35.CrossRefPubMed
21.
Zurück zum Zitat Lipstein EA, Vorono S, Browning MF, Green NS, Kemper AR, Knapp AA, et al. Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency. Pediatrics. 2010;25:1226–35.CrossRef Lipstein EA, Vorono S, Browning MF, Green NS, Kemper AR, Knapp AA, et al. Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency. Pediatrics. 2010;25:1226–35.CrossRef
22.
Zurück zum Zitat Al-Herz W, Al-Mousa H. Combined immunodeficiency: the Middle East experience. J Allergy Clin Immunol. 2013;131(3):658–60.CrossRefPubMed Al-Herz W, Al-Mousa H. Combined immunodeficiency: the Middle East experience. J Allergy Clin Immunol. 2013;131(3):658–60.CrossRefPubMed
24.
Zurück zum Zitat Ouederni M, Vincent QB, Frange P, Touzot F, Scerra S, Bejaoui M, et al. Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood. 2011;118(19):5108–18.CrossRefPubMed Ouederni M, Vincent QB, Frange P, Touzot F, Scerra S, Bejaoui M, et al. Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood. 2011;118(19):5108–18.CrossRefPubMed
25.
Zurück zum Zitat Al-Mousa H, Al-Shammari Z, Al-Ghonaium A, Al-Dhekri H, Al-Muhsen S, Al-Saud B, et al. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency. Biol Blood Marrow Transpl. 2010;16(6):818–23.CrossRef Al-Mousa H, Al-Shammari Z, Al-Ghonaium A, Al-Dhekri H, Al-Muhsen S, Al-Saud B, et al. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency. Biol Blood Marrow Transpl. 2010;16(6):818–23.CrossRef
27.
Zurück zum Zitat Woroniecka M, Ballow M. Office evaluation of children with recurrent infection. Paediatr Clin N Am. 2000;47(6):1211–24.CrossRef Woroniecka M, Ballow M. Office evaluation of children with recurrent infection. Paediatr Clin N Am. 2000;47(6):1211–24.CrossRef
30.
Zurück zum Zitat Gathmann B, Grimbacher B, Beauté J, Dudoit Y, Mahlaoui N, Fischer A, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2006–2008. Clin Exp Immunol. 2009;157 Suppl 1:3–11.PubMedCentralCrossRefPubMed Gathmann B, Grimbacher B, Beauté J, Dudoit Y, Mahlaoui N, Fischer A, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2006–2008. Clin Exp Immunol. 2009;157 Suppl 1:3–11.PubMedCentralCrossRefPubMed
31.
Zurück zum Zitat Ehlayel MS, Bener A, Laban MA. Primary immunodeficiency diseases in children: 15 year experience in a tertiary care medical center in Qatar. J Clin Immunol. 2013;33(2):317–24.CrossRefPubMed Ehlayel MS, Bener A, Laban MA. Primary immunodeficiency diseases in children: 15 year experience in a tertiary care medical center in Qatar. J Clin Immunol. 2013;33(2):317–24.CrossRefPubMed
32.
Zurück zum Zitat Bousfiha AA, Jeddane L, El Hafidi N, Benajiba N, Rada N, El Bakkouri J, et al. First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998–2012). J Clin Immunol. 2014;34(4):459–68.PubMed Bousfiha AA, Jeddane L, El Hafidi N, Benajiba N, Rada N, El Bakkouri J, et al. First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998–2012). J Clin Immunol. 2014;34(4):459–68.PubMed
33.
Zurück zum Zitat Plotkin SA, Orenstein WA, Offit PA. Vaccines. 6th ed. Edinburgh: Elsevier/Saunders; 2013. Plotkin SA, Orenstein WA, Offit PA. Vaccines. 6th ed. Edinburgh: Elsevier/Saunders; 2013.
34.
Zurück zum Zitat Alrabiaah AA, Alsubaie SS, Bukhari EI, Gad A, Alzamel FA. Outbreak of Bacille Calmette-Guérin-related lymphadenitis in Saudi children at a university hospital after a change in the strain of vaccine. Ann Saudi Med. 2012;32(1):4–8.PubMed Alrabiaah AA, Alsubaie SS, Bukhari EI, Gad A, Alzamel FA. Outbreak of Bacille Calmette-Guérin-related lymphadenitis in Saudi children at a university hospital after a change in the strain of vaccine. Ann Saudi Med. 2012;32(1):4–8.PubMed
35.
Zurück zum Zitat Bernatowska E, Wolska-Kusnierz B, Pac M, Kurenko-Deptuch M, Zwolska Z, Casanova J, et al. Disseminated bacillus calmette-guérin infection and immunodeficiency. Emerg Infect Dis. 2007;13(5):799–801.PubMedCentralCrossRefPubMed Bernatowska E, Wolska-Kusnierz B, Pac M, Kurenko-Deptuch M, Zwolska Z, Casanova J, et al. Disseminated bacillus calmette-guérin infection and immunodeficiency. Emerg Infect Dis. 2007;13(5):799–801.PubMedCentralCrossRefPubMed
36.
Zurück zum Zitat I˙kinciogˇulları A, Dogˇu F, iftci E, nal E, Ertem M, Reisli I, et at. An intensive approach to the treatment of disseminated BCG infection in a SCID patient. Bone Marrow Transplantation. 2002; 30, 45–47. I˙kinciogˇulları A, Dogˇu F, iftci E, nal E, Ertem M, Reisli I, et at. An intensive approach to the treatment of disseminated BCG infection in a SCID patient. Bone Marrow Transplantation. 2002; 30, 45–47.
37.
Zurück zum Zitat Paiman S, Siadati A, Mamishi S, Tabatabaie P, Khotaee G. Disseminated mycobacterium bovis infection after BCG vaccination. Iran J Allergy Asthma Immunol. 2006;5(3):133–7. Paiman S, Siadati A, Mamishi S, Tabatabaie P, Khotaee G. Disseminated mycobacterium bovis infection after BCG vaccination. Iran J Allergy Asthma Immunol. 2006;5(3):133–7.
38.
Zurück zum Zitat Marciano B, Huang C, Joshi G, Rezaei N, Carvalho B, Allwood Z, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol. 2014;133:1134–41.PubMedCentralCrossRefPubMed Marciano B, Huang C, Joshi G, Rezaei N, Carvalho B, Allwood Z, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol. 2014;133:1134–41.PubMedCentralCrossRefPubMed
39.
Zurück zum Zitat Chan K, Puck JM. Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol. 2005;115(2):391–8.CrossRefPubMed Chan K, Puck JM. Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol. 2005;115(2):391–8.CrossRefPubMed
40.
Zurück zum Zitat Chan K, Davis J, Pai SY, Bonilla FA, Puck JM, Apkon M. A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID). Mol Genet Metab. 2011;104:383–9.PubMedCentralCrossRefPubMed Chan K, Davis J, Pai SY, Bonilla FA, Puck JM, Apkon M. A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID). Mol Genet Metab. 2011;104:383–9.PubMedCentralCrossRefPubMed
Metadaten
Titel
Primary Immunodeficiency Diseases in Saudi Arabia: a Tertiary Care Hospital Experience over a Period of Three Years (2010–2013)
verfasst von
Bandar Al-Saud
Hamoud Al-Mousa
Sulaiman Al Gazlan
Abdulaziz Al-Ghonaium
Rand Arnaout
Amal Al-Seraihy
Sahar Elshorbagi
Nazeema Elsayed
Jawad Afzal
Hasan Al-Dhekri
Saleh Al-Muhsen
Publikationsdatum
01.10.2015
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 7/2015
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-015-0197-6

Weitere Artikel der Ausgabe 7/2015

Journal of Clinical Immunology 7/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.